Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Interview with Dr. Hyman Muss at 2008 ASCO Meeting

Loading...

Sign in or sign up now!
557 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon
Ratings have been disabled for this video.

Uploaded by on Jun 18, 2008

Elsevier Global Medical News/Oncology Stat interviews Dr. Hyman Muss on the CALGB/CTSU 49907 trial. The study compared the oral agent capecitabine with standard chemo in women over age 65 with early-stage breast cancer. Interviewer: Mary Ellen Schneider, EGMN

All Comments

Adding comments has been disabled for this video.

0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more